BMC cardiovascular disorders · 2025
Prognostic significance of HANBAH score in evaluating mortality and major adverse cardiovascular events in patients with diabetes mellitus.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aydemir Selim, Aydın Sidar Şiyar, Altınkaya Onur, Özmen Murat, Çomaklı Nurullah, Aksakal Emrah
Аннотация
BACKGROUND: Predicting mortality and major adverse cardiovascular events (MACE) in Type 2 diabetes mellitus (T2DM) is important, but no routinely recommended risk score exists. The HANBAH Score is a recently established risk score for mortality prediction in acute heart failure. This study aimed to investigate the relationship between the HANBAH Score and mortality and MACE in T2DM patients.
METHODS: This study was retrospective, and patients who applied to the outpatient clinic diagnosed with T2DM were included. The patients' HANBAH Score was calculated. The relationship between the HANBAH score and mortality and MACE was examined.
RESULTS: 7611 T2DM patients were included in this study. The mean age of the patients was 59.1 ± 12.8 years, and 3187 (41.9%) were male. The mortality rate was 1% (76 patients), and the MACE rate was 5.8% (438 patients). The mean follow-up time was 604 days. HANBAH Score was an independent predictor of mortality (HR: 2.260, 95%CI:1.738-2.939, p < 0.001) and MACE (HR: 1.238, 95%CI:1.094-1.400, p < 0.001). ROC curve analysis showed that HANBAH Score highly predicted mortality (AUC: 0.846, 95%CI: 0.794-0.898, p < 0.001).
CONCLUSIONS: This study showed that the HANBAH Score is a predictor of MACE and mortality in patients with T2DM.
METHODS: This study was retrospective, and patients who applied to the outpatient clinic diagnosed with T2DM were included. The patients' HANBAH Score was calculated. The relationship between the HANBAH score and mortality and MACE was examined.
RESULTS: 7611 T2DM patients were included in this study. The mean age of the patients was 59.1 ± 12.8 years, and 3187 (41.9%) were male. The mortality rate was 1% (76 patients), and the MACE rate was 5.8% (438 patients). The mean follow-up time was 604 days. HANBAH Score was an independent predictor of mortality (HR: 2.260, 95%CI:1.738-2.939, p < 0.001) and MACE (HR: 1.238, 95%CI:1.094-1.400, p < 0.001). ROC curve analysis showed that HANBAH Score highly predicted mortality (AUC: 0.846, 95%CI: 0.794-0.898, p < 0.001).
CONCLUSIONS: This study showed that the HANBAH Score is a predictor of MACE and mortality in patients with T2DM.